NTRK Fusions Identified in Pediatric Tumors: The Frequency, Fusion Partners, and Clinical Outcome

Neurotrophic tyrosine receptor kinase (NTRK) fusions have been described as oncogenic drivers in a variety of tumors. However, little is known about the overall frequency of NTRK fusion in unselected pediatric tumors. Here, we assessed the frequency, fusion partners, and clinical course in pediatric...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:JCO Precis Oncol
Asıl Yazarlar: Zhao, Xiaonan, Kotch, Chelsea, Fox, Elizabeth, Surrey, Lea F., Wertheim, Gerald B., Baloch, Zubair W., Lin, Fumin, Pillai, Vinodh, Luo, Minjie, Kreiger, Portia A., Pogoriler, Jennifer E., Linn, Rebecca L., Russo, Pierre A., Santi, Mariarita, Resnick, Adam C., Storm, Phillip B., Hunger, Stephen P., Bauer, Andrew J., Li, Marilyn M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Clinical Oncology 2021
Konular:
ORIGINAL REPORTS
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8140782/
https://ncbi.nlm.nih.gov/pubmed/34036219
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/PO.20.00250
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller